Jeffrey Mitchell
Director of Finance/CFO chez LEXAGENE HOLDINGS INC.
Fortune : 28 076 $ au 31/01/2023
Profil
Jeffrey Mitchell is currently the Chief Financial Officer, Secretary & Treasurer at Lexagene Holdings, Inc. since 2018.
Prior to this, he worked as a Finance Director & Controller at Palomar Medical Technologies LLC.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
LEXAGENE HOLDINGS INC.
0,11% | 19/12/2022 | 152 585 ( 0,11% ) | 28 076 $ | 31/01/2023 |
Postes actifs de Jeffrey Mitchell
Sociétés | Poste | Début |
---|---|---|
LEXAGENE HOLDINGS INC. | Director of Finance/CFO | 01/03/2018 |
Anciens postes connus de Jeffrey Mitchell
Sociétés | Poste | Fin |
---|---|---|
PALOMAR MEDICAL TECHNOLOGIES INC | Director of Finance/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LEXAGENE HOLDINGS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Palomar Medical Technologies LLC
Palomar Medical Technologies LLC Electronic ComponentsElectronic Technology Palomar Medical Technologies LLC engages in the research, development, manufacturing and distribution of light based systems for cosmetic treatments. The company is involved in developing a differentiated product mix of light-based systems for various treatments through its research and development as well as with its partnerships throughout the world. It is continually developing and testing new indications to further the advancement in light-based treatments. The company operates through two segments: Professional Product and Consumer Product. The Professional Product segment includes all of its light-based products and services for the professional market. The Consumer Product segment includes PaloVia. It offers products based on technologies that include hair removal, body sculpting, including laser-assisted liposuction, removal of vascular lesions such as rosacea, spider veins, port wine stains and hemangiomas, wrinkle reduction, removal of leg veins, removal of benign pigmented lesions such as age and sun spots, freckles and melasma, tattoo removal, acne treatment, skin resurfacing, treatment of red pigmentation in hypertrophic and keloid scars, treatment of verrucae, skin tags, seborrheic keratosis, skin tightening through soft tissue coagulation, removal of scars, including acne scars, stretch marks and warts and soft tissue coagulation. Palomar Medical Technologies was founded in 1987 and is headquartered in Burlington, MA. | Electronic Technology |